Vor Biopharma Inc.
Price Action
Technical Summary
EMERGING TRENDVor Biopharma Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 82), indicating clear outperformance against the broad market. Earnings contraction of 97% provides fundamental context to the price action. However, with RSI at 76, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $15.51 | +29.57% | ABOVE |
| 50 SMA | $15.13 | +32.82% | ABOVE |
| 100 SMA | $14.95 | +34.44% | ABOVE |
| 150 SMA | $14.22 | +41.37% | ABOVE |
| 200 SMA | $16.94 | +18.68% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is VOR in an uptrend right now?
VOR has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is VOR overbought or oversold?
VOR's RSI (14) is 76. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is VOR outperforming the market?
VOR has a Relative Strength (RS) Rating of 82 out of 99. Yes, VOR is a market leader, outperforming 82% of all stocks over the past 12 months.
Where is VOR in its 52-week range?
VOR is trading at $20.10, which is 31% of its 52-week high ($65.80) and 23% above its 52-week low ($6.50).
How volatile is VOR?
VOR has a Beta of 1.07 and 52-week volatility of 126%. It's more volatile than the S&P 500 - expect bigger swings.